Lindsay Allen
Vice President, Investor Relations and Communications
Replay available
Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2025 Earnings Call
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Justin Klee
Co-CEO
Dr. Camille Bedrogian
Chief Medical Officer
Jim Fradies
Chief Financial Officer
Josh Cohen
Co-CEO
Seamus Fernandez
Analyst, Guggenheim
Joseph Thome
Analyst, TD Cowen
Michael DeFiori
Analyst, Evercore
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Amylyx Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:04.600 Good morning. My name is John and I'll be your conference operator today. 00:00:04.600 -- 00:00:10.520 At this time, I would like to welcome everyone to the MLX Parameciedicals 00:00:10.520 -- 00:00:15.620 second quarter earnings conference call. All participants will be 00:00:15.620 -- 00:00:20.340 in the listen only mode. After today's presentation, 00:00:20.340 -- 00:00:22.980 there will be an opportunity to ask questions. 00:00:22.980 -- 00:00:28.340 To ask a question, please press star on your telephone keypad. 00:00:28.340 -- 00:00:32.500 To withdraw your question, please press star 2. 00:00:32.500 -- 00:00:38.140 Please limit your questions to one question with one follow-up. 00:00:38.140 -- 00:00:43.060 If you would like to add additional questions, 00:00:43.360 -- 00:00:49.060 you may rejoin the queue. Please be advised that this call is being recorded at 00:00:49.060 -- 00:00:54.260 the company's request. I would now like to turn the call over to Lindsay Allen, Vice 00:00:54.260 -- 00:00:57.780 President, Investor Relations and Communications. 00:00:57.780 -- 00:00:58.680 Please go ahead, ma 00:00:58.680 -- 00:01:00.680 'am. 00:01:04.100 -- 00:01:09.590 Good morning and thank you all for joining us today to discuss our second quarter 2025 00:01:09.590 -- 00:01:14.800 financial results and business updates. With me on the call today are Josh Cohen 00:01:14.800 -- 00:01:20.220 and Justin Klee, our co-CEOs, Dr. Camille Bedrogian, our Chief Medical 00:01:20.220 -- 00:01:24.400 Officer, and Jim Fradies, our Chief Financial Officer. 00:01:24.400 -- 00:01:29.520 Before we begin, I would like to remind everyone that any statements we make or information 00:01:29.520 -- 00:01:34.760 presented on this call that are not historical f...